KUWAIT: Just a
few days before one of the world's largest health and medical conferences -
Arab Health - took place, Kuwait scored an important medical milestone with the
first cardiac ablation treatment done in the private sector. Cardiac ablation
is a complex cardiac procedure used to treat abnormal electrical activity in
the heart.

Given the complex
nature of the treatment, cardiac ablation is usually done by only a handful of
trained cardiologists in Kuwait's public sector hospitals. But thanks to a
collaboration between Kuwait's Central Circle medical company and Johnson &
Johnson Middle East, the cutting-edge treatment is now available in the private
healthcare sector in Kuwait.

A team of leading
doctors including electrophysiologist Dr Fawzia Alkandari performed the
groundbreaking and complex procedure at Hadi Hospital. The event is a major
leap in the right direction in acknowledging the importance of such treatments,
which shouldn't be held from patients in need. The cardiac ablation was covered
by insurance. Johnson & Johnson is a top manufacturer of the ablation
technology. They have partnered with Central Circle in Kuwait to bring this
innovative treatment to the private sector.

"A vital
treatment such as ablation therapy should be made accessible to all those who
need it," stated Dr Ziad Al-Alyan, Central Circle CEO. Dr Al-Alyan thanked
the great Johnson & Johnson team and the team at Hadi Hospital for making
the groundbreaking treatment become a reality. Cardiac arrhythmia is relatively
common in Kuwait due to the high prevalence of heart disease in the region.
Having the private sector contribute in the treatment availability reduces wait
times for patients and results in better outcomes for public health in general.